BETA: Please send your feedback!
Ultragenyx Pharmaceutical
RARE:NAS
Biotechnology
—
MID cap
(—)
—
since start of 2021
—
- 2
- 3
- 1
- 3
- —
- 5
- 3
- 2
- —
- —
- 1
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Biotechnology
Founded 2010
Ultragenyx Pharmaceutical, Inc. is a clinical-stage biotechnology company, which is focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. It intends to build therapies to address these clinically underserved diseases. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.
website
Headquarters
Executives
Name | Title | Gender |
Emil D. Kakkis, MD, PhD | President, Chief Executive Officer & Director | Male |
Daniel G. Welch, MBA | Non-Executive Chairman | Male |
Shalini Sharp, MBA | CFO, Senior VP & Head-Investor Relations | Female |
Dennis Karl Huang | Chief Technical Operations Officer & Senior VP | Male |
Karah Parschauer | Executive Vice President & General Counsel | Female |
Mindful Investing Summary
Ultragenyx Pharmaceutical - Competitors and Related Companies
How Ultragenyx Pharmaceutical stacks up to its peers in the Biotechnology industry or with competing business segments.
Ultragenyx Pharmaceutical
RARE:NAS
Biotechnology
—
MID cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 4
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Amicus Therapeutics
FOLD:NAS
Biotechnology
—
MID cap
(—)
—
since start of 2021
—
- 2
- 3
- 1
- 3
- —
- 5
- 3
- 2
- —
- —
- 1
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Esperion Therapeutics
ESPR:NAS
Biotechnology
—
MID cap
(—)
—
since start of 2021
—
- 2
- 3
- 1
- 3
- —
- 5
- 3
- 2
- —
- —
- 1
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Alexion Pharmaceuticals
ALXN:NAS
Biotechnology
—
LARGE cap
(—)
—
since start of 2021
—
- 5
- 5
- 4
- 5
- —
- 4
- 5
- 4
- —
- —
- —
- 4
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Lexicon Pharmaceuticals
LXRX:NAS
Biotechnology
—
SMALL cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 1
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Versartis
VSAR:NAS
Biotechnology
—
MICRO cap
(—)
—
since start of 2021
—
- 2
- 3
- 1
- 3
- —
- 5
- 3
- 2
- —
- —
- 1
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership